Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 83.44 1.03 (1.25%) | NSE 83.76 1.31 (1.59%) | Trade | Add

BSE Live

Oct 24, 16:01

83.44 1.03 (1.25%)

Volume

AVERAGE VOLUME

5-Day

852

10-Day

719

30-Day

3,783

577

Prev. Close

82.41
Open Price

82.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 24, 15:59

83.76 1.31 (1.59%)

Volume

AVERAGE VOLUME

5-Day

12,724

10-Day

13,064

30-Day

30,184

19,448

Prev. Close

82.45
Open Price

81.99

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
83.76 (49)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	14.17	14.17	14.17	14.17	12.87
Total Share Capital	14.17	14.17	14.17	14.17	12.87
Reserves and Surplus	51.77	62.69	58.06	52.41	41.81
Total Reserves and Surplus	51.77	62.69	58.06	52.41	41.81
Total Shareholders Funds	65.94	76.86	72.23	66.59	56.70
NON-CURRENT LIABILITIES
Long Term Borrowings	23.15	28.76	34.68	17.80	15.94
Deferred Tax Liabilities [Net]	4.05	4.18	7.56	7.74	6.96
Other Long Term Liabilities	2.67	1.65	1.28	1.05	0.90
Long Term Provisions	3.55	2.66	2.02	3.35	2.23
Total Non-Current Liabilities	33.42	37.24	45.53	29.94	26.02
CURRENT LIABILITIES
Short Term Borrowings	70.61	68.06	49.29	52.05	50.09
Trade Payables	39.45	47.49	49.95	53.55	46.75
Other Current Liabilities	29.40	27.00	33.73	16.52	11.54
Short Term Provisions	0.49	0.50	0.37	0.19	2.24
Total Current Liabilities	139.95	143.05	133.33	122.32	110.62
Total Capital And Liabilities	239.31	257.15	251.10	218.84	193.33
ASSETS
NON-CURRENT ASSETS
Tangible Assets	49.74	51.27	53.82	55.06	51.33
Intangible Assets	6.39	5.67	4.47	4.66	4.62
Capital Work-In-Progress	0.11	0.06	0.21	1.70	3.93
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	56.24	57.00	58.50	61.43	59.88
Non-Current Investments	7.42	7.44	7.44	0.02	1.18
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.25	1.86	2.37	2.10	7.52
Other Non-Current Assets	2.94	3.49	1.31	4.95	0.32
Total Non-Current Assets	66.84	69.79	69.62	68.49	68.89
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	67.55	69.52	66.17	54.37	41.61
Trade Receivables	51.66	65.69	64.06	61.01	56.82
Cash And Cash Equivalents	2.95	4.08	4.03	4.61	4.46
Short Term Loans And Advances	17.44	13.58	7.54	0.60	21.27
OtherCurrentAssets	32.88	34.49	39.69	29.77	0.28
Total Current Assets	172.47	187.37	181.48	150.35	124.44
Total Assets	239.31	257.15	251.10	218.84	193.33
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	12.99	20.37	8.93	12.91	20.49
CIF VALUE OF IMPORTS
Raw Materials	0.00	36.23	41.23	58.16	48.61
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.29	0.41	0.21
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	2.63	2.80	1.65	1.91	1.35
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	103.45	126.56	98.73	115.45	109.41
Other Earnings	--	--	--	--	--
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	8.59	7.44	7.44	1.18	1.18
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--